TY - JOUR
T1 - Barriers of healthcare providers against end-of-life discussions with pediatric cancer patients
AU - Yoshida, Saran
AU - Shimizu, Ken
AU - Kobayashi, Mariko
AU - Inoguchi, Hironobu
AU - Oshima, Yoshio
AU - Dotani, Chikako
AU - Nakahara, Rika
AU - Takahashi, Tomomi
AU - Kato, Masashi
PY - 2014/8
Y1 - 2014/8
N2 - Objective: End-of-life discussions with patients can be one of the most dif?cult and stressful tasks for the oncologist. However, little is known about the discussions that healthcare providers have with patients in such situations and the dif?culties they face. The primary end points of this study were to describe the contents of end-of-life discussion in the pediatric setting and the barriers to end-of-life discussion for pediatric patients, as perceived by pediatric healthcare providers. Methods: Participants were 10 healthcare providers. Semi-structured interviews were conducted, and the KJ method was performed to analyze the data. Results: We found 23 barriers against end-of-life discussion with pediatric cancer patients. These barriers were classi?ed as follows: healthcare provider factors, patient factors, parent factors and institutional or cultural factors. In addition to barriers found in previous studies, some unique barriers were uncovered such as, 'Lack of con?dence to face the patient after the discussion', 'Uncertain responsibility for treatment decision-making' and 'No compelling reason to discuss'. Healthcare providers actively discussed the purpose of treatment and the patients' wishes and concerns; however, they were reluctant to deal with the patients' own impending death and their estimated prognosis. Conclusions: End-of-life discussion with pediatric patients differs from that with adult patients. Further studies are required to analyze pediatric cases associated with end-of-life discussion and carefully discuss its adequacy, pros and cons.
AB - Objective: End-of-life discussions with patients can be one of the most dif?cult and stressful tasks for the oncologist. However, little is known about the discussions that healthcare providers have with patients in such situations and the dif?culties they face. The primary end points of this study were to describe the contents of end-of-life discussion in the pediatric setting and the barriers to end-of-life discussion for pediatric patients, as perceived by pediatric healthcare providers. Methods: Participants were 10 healthcare providers. Semi-structured interviews were conducted, and the KJ method was performed to analyze the data. Results: We found 23 barriers against end-of-life discussion with pediatric cancer patients. These barriers were classi?ed as follows: healthcare provider factors, patient factors, parent factors and institutional or cultural factors. In addition to barriers found in previous studies, some unique barriers were uncovered such as, 'Lack of con?dence to face the patient after the discussion', 'Uncertain responsibility for treatment decision-making' and 'No compelling reason to discuss'. Healthcare providers actively discussed the purpose of treatment and the patients' wishes and concerns; however, they were reluctant to deal with the patients' own impending death and their estimated prognosis. Conclusions: End-of-life discussion with pediatric patients differs from that with adult patients. Further studies are required to analyze pediatric cases associated with end-of-life discussion and carefully discuss its adequacy, pros and cons.
KW - Barrier
KW - End-of-life discussion
KW - Pediatric cancer
KW - Qualitative study
UR - http://www.scopus.com/inward/record.url?scp=84905261869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905261869&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyu077
DO - 10.1093/jjco/hyu077
M3 - Article
C2 - 24903853
AN - SCOPUS:84905261869
SN - 0368-2811
VL - 44
SP - 729
EP - 735
JO - Japanese Journal of Clinical Oncology
JF - Japanese Journal of Clinical Oncology
IS - 8
ER -